Tiger Brokers

  • Quotes
  • Invest
  • Pricing
  • Download
  • Rewards
  • Help
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
    • Esop
  • About
    • About us
    • Newsroom
    • Awards
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

ATYR PHARMA INC

0.5183
+0.01683.35%
Volume:626.84K
Turnover:320.90K
Market Cap:50.79M
PE:-0.83
High:0.5340
Open:0.5106
Low:0.4900
Close:0.5015
52wk High:6.50
52wk Low:0.3950
Shares:97.99M
Float Shares:95.97M
Volume Ratio:1.03
T/O Rate:0.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6214
EPS(LYR):-0.7971
ROE:-98.68%
ROA:-46.58%
PB:1.04
PE(LYR):-0.65

Loading ...

OverviewCompanyNewsFilings

aTyr Pharma Inc expected to post a loss of 15 cents a share - Earnings Preview

Reuters
·
May 08

BRIEF-aTyr Pharma Q1 Net Income USD -166.391 Million

Reuters
·
May 07

aTyr Pharma Q1 Income From Operations USD -163.314 Million

THOMSON REUTERS
·
May 07

aTyr Pharma Inc expected to post a loss of 15 cents a share - Earnings Preview

Reuters
·
May 01

Analysts Offer Insights on Healthcare Companies: aTyr Pharma (ATYR) and Idexx Laboratories (IDXX)

TIPRANKS
·
Apr 07

Atyr Pharma Faces Nasdaq Delisting Risk After Minimum Bid Price Violation

TIPRANKS
·
Mar 07

aTyr Pharma Q4 EPS $(0.14) Beats $(0.16) Estimate

Benzinga Earnings
·
Mar 06

aTyr posts FY 2025 net loss of USD 74.1 million

Reuters
·
Mar 06

aTyr Pharma Inc: Qtrly Shr Loss $0.14

THOMSON REUTERS
·
Mar 06

Press Release: aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update

Dow Jones
·
Mar 06

aTyr Pharma Awards Inducement Stock Options Under Nasdaq Rule 5635(c)(4)

Reuters
·
Feb 21

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Feb 21

Analyst Rate

Buy
Buy
44.44%
Hold
55.56%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 07, 2026 Post-Mkt
Financial Report Announcement
May 15, 2026 Pre-MKt
Financial Report Announcement
Mar 05, 2026 Post-Mkt
Financial Report Announcement
Nov 06, 2025 Post-Mkt
Financial Report Announcement
Aug 07, 2025 Post-Mkt

Dividend History

no data

No relevant data is available

Valuation Analysis

-0.83
Current
-3.11
Sector Average
90.24%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-0.83
Maximum
-0.65
+1 STD
-0.78
Minimum
-8.13
-1 STD
-5.45
Average
-3.11

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.